Pharmaceutical preparations

JP7874941B2Active Publication Date: 2026-06-17ROHTO PHARM CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
ROHTO PHARM CO LTD
Filing Date
2021-05-28
Publication Date
2026-06-17

AI Technical Summary

Technical Problem

Conventional gastrointestinal drugs containing sodium-based antacids and belladonna extract are not suitable for the elderly or those with reduced physical strength, as they can raise blood pressure and cause anticholinergic effects, and their formulation stability is impaired when these components are excluded.

Method used

Formulating gastrointestinal medications with calcium-based and magnesium-based antacids, along with digestive enzymes, to improve stability in formulations that exclude sodium-based antacids and belladonna extract, enhancing adhesion, hygroscopicity, and turbidity in aqueous media.

Benefits of technology

The formulation achieves improved stability, preventing adhesion, hygroscopicity, and turbidity issues, ensuring effective absorption and maintaining the quality of the active ingredients, making it suitable for the elderly and those with underlying health conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007874941000001
    Figure 0007874941000001
  • Figure 0007874941000002
    Figure 0007874941000002
  • Figure 0007874941000003
    Figure 0007874941000003
Patent Text Reader

Abstract

To provide a pharmaceutical preparation that has improved stability even when prepared excluding sodium-based antacids and Scopolia extract.SOLUTION: A pharmaceutical preparation contains (A) at least one antacid selected from the group consisting of calcium-based antacids and magnesium-based antacids and (B) digestive enzymes, but is substantially free of sodium-based antacids and Scopolia extract.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art